Trial Profile
CBT Augmentation of SSRI Treatment for Geriatric GAD.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Generalised anxiety disorder
- Focus Therapeutic Use
- 17 May 2013 Primary endpoint 'Penn-State-Worry-Questionnaire' has been met according to results published in the American Journal of Psychiatry.
- 01 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Aug 2011 Planned end date changed from 1 Jul 2010 to 1 Sep 2011 as reported by ClinicalTrials.gov.